Thalidomide in type-2 lepra reaction--a clinical experience.
Indian J Lepr
;
1990 Jul-Sep; 62(3): 316-20
Artículo
en Inglés
| IMSEAR
| ID: sea-54668
ABSTRACT
A clinical experience of using thalidomide in type-2 lepra reaction (ENL) in 90 male patients--57 with lepromatous leprosy (LL) and 33 with borderline lepromatous leprosy (BL)--is described. All the patients responded well although some took a longer time to improve. No major side effects were observed except for giddiness in 10 and gastrointestinal upsets in 7 patients. Thalidomide thus appears to be a very effective drug in the treatment of severe type-2 lepra reaction and apart from its historically well-documented embryopathic effects, does not seem to have any other serious side effects in the patients under study.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Talidomida
/
Humanos
/
Masculino
/
Lepra Lepromatosa
/
Antiinflamatorios no Esteroideos
/
Adolescente
/
Adulto
/
Quimioterapia Combinada
/
Persona de Mediana Edad
Idioma:
Inglés
Revista:
Indian J Lepr
Asunto de la revista:
Tropical Medicine
Año:
1990
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS